Healthcare


COVID-19 Survey

What Worries the World - February 2022

The global public’s top 5 concerning issues remain unchanged, with Covid-19 still top. But inflation now ranks 6th with almost one in four (23%) worldwide now saying it is a worry in their country.
Healthcare Survey

American Healthcare Workers Persevering, but Remain Stressed

New USA Today-Ipsos survey of healthcare workers finds one in three thinks the system is on the verge of collapse
Healthcare Publication

Conquering Complexity: The ongoing revolution in oncology biomarker testing

The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalized medicine now well-entrenched in the treatment paradigm.
Patients Survey

Negative perspectives on experience at hospitals increase 10 points from Q1

The Beryl Institute-Ipsos PX Pulse trends consumer perspectives on patient experience.
Society Webinar

[WEBINAR RECORDING] The Future of point of care (PoC) & rapid testing

How has the Point of Care (PoC) and rapid testing market evolved, and what does the future hold?
Healthcare Survey

More than four in five physicians/pharmacists believe that longer prescriptions could increase patient adherence and improve chronic condition management

New RO Pharmacy/Ipsos poll finds that most physicians would write longer prescriptions if they could
Healthcare Publication

Insights For Pharma: Helping ‘Challenger’ Brands Win

Discover tips for how a “challenger” brand can make a mark, and ultimately win at launch...
Healthcare Survey

Americans rank mental health, cancer, drug abuse, and obesity as nation’s top health issues after COVID

Waiting times and lack of staff are perceived as the biggest problems with most countries’ healthcare system while cost of treatment tops the list in the U.S.: 2021 Global Health Service Monitor
Healthcare Publication

Oncology: the disease, dynamics & challenges of market research

The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.